New biopsy technique may improve sarcoidosis diagnosis
NCT ID NCT07246876
First seen Jan 04, 2026 · Last updated Jun 23, 2026 · Updated 32 times
Summary
This study will compare two ways to diagnose sarcoidosis, a disease that causes inflammation and lumps (granulomas) in the lungs. About 469 people with suspected stage I or II sarcoidosis will be randomly assigned to receive either a newer method called EBUS-guided cryobiopsy or the standard combination of biopsies. The goal is to see which approach finds granulomas more often and has fewer complications.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARCOIDOSIS, PULMONARY are added.
Genom att skicka in godkänner du våra Användarvillkor
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If this trial succeeds, it could show that a newer biopsy method (cryobiopsy) is better at diagnosing sarcoidosis than the current standard approach.
What could go wrong
This is a diagnostic study, not a treatment trial. Even if one method is more accurate, it may not change patient outcomes. The trial has not yet started recruiting.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.